Tranexamic acid-13C6

CAT:
804-HY-B0149S2
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tranexamic acid-13C6 - image 1

Tranexamic acid-13C6

  • Description :

    Tranexamic acid-13C6 (Cyclocapron-13C6) is 13C labeled Tranexamic acid. Tranexamic acid (cyclocapron), a cyclic analog of lysine, is an orally active antifibrinolytic agent. Tranexamic acid attenuates the effects of severe trauma, inhibits urokinase plasminogen activator and ameliorates dry wrinkles. Tranexamic acid can used for the research of hemostasis [1][2][3][4][5].
  • Product Name Alternative :

    Cyclocapron-13C6
  • UNSPSC :

    12352211
  • Target :

    AMPK; IGF-1R; Isotope-Labeled Compounds; Mitophagy; MMP
  • Related Pathways :

    Autophagy; Epigenetics; Metabolic Enzyme/Protease; Others; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK
  • Applications :

    Cancer-Kinase/protease
  • Field of Research :

    Cancer; Neurological Disease; Cardiovascular Disease
  • Smiles :

    O=C([13C@]1[13C][13C][13C@](CN)[13C][13C]1)O
  • Molecular Formula :

    C2 13C6H5NO2
  • Molecular Weight :

    153.09
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Prudovsky I, et al. Tranexamic acid suppresses the release of mitochondrial DNA, protects the endothelial monolayer and enhances oxidative phosphorylation [J]. Journal of cellular physiology, 2019, 234 (11) : 19121-19129.|[3]Wu G, et al. Tranexamic acid is an active site inhibitor of urokinase plasminogen activator [J]. Blood advances, 2019, 3 (5) : 729-733.|[4]Draxler D F, et al. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis [J]. Journal of Thrombosis and Haemostasis, 2019, 17 (12) : 2174-2187.|[5]Hiramoto K, et al. The amelioration effect of tranexamic acid in wrinkles induced by skin dryness [J]. Biomedicine & Pharmacotherapy, 2016, 80: 16-22.|[6]Sindet-Pedersen S, et al. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery [J]. New England Journal of Medicine, 1989, 320 (13) : 840-843.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide